Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation
Mm. Rahme et al., Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation, CIRCULATION, 100(19), 1999, pp. 2010-2017
Citations number
39
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Stimulation of 5-HT4 receptors increases atrial chronotropic and
inotropic responses. Whether other electrophysiological effects are produc
ed is unknown. In humans and swine, 5-HT4 receptors are present only in atr
ium. Therefore, the effects of a novel 5-HT4 receptor antagonist, RS-100302
, and the partial agonist cisapride on atrial flutter and fibrillation indu
ced in swine were studied to delineate the role of the 5-HT4 receptor in mo
dulating atrial electrophysiological properties and the antiarrhythmic pote
ntial of RS-100302.
Methods and Results-In 17 anesthetized, open-chest, juvenile pigs, atrial f
lutter or fibrillation was induced by rapid right atrial pacing with or wit
hout a right: atrial free wall crush injury, respectively. Atrial effective
refractory period (ERP), conduction velocity, wavelength, and dispersion o
f refractoriness were determined during programmed stimulation via a 56-ele
ctrode mapping plaque sutured to the right atrial Free wall. Ventricular el
ectrophysiological parameters were also measured. All electrophysiological
parameters were measured at baseline and after infusion of RS-100302 and ci
sapride. In the atrium, RS-100302 prolonged mean ERP (115 +/- 8 versus 146
+/- 7 ms, P < 0.01) and wavelength (8.3 +/- 0.9 versus 9.9 +/- 0.8 cm, P <
0.01), reduced dispersion of ERP (15 +/- 5 versus 8 +/- 1 ms, P < 0.01), an
d minimally slowed conduction velocity (72 +/- 4 versus 67 +/- 5 cm/s, P <
0.01). These effects were all partially reversed by cisapride. RS-100302 pr
oduced no ventricular electrophysiological effects. RS-100302 terminated at
rial flutter in 6 of 8 animals and atrial fibrillation in 8 of 9 animals an
d prevented reinduction of sustained tachycardia in all animals.
Conclusions-The electrophysiological profile of RS-100302 suggests that it
may have atrial antiarrhythmic potential without producing ventricular proa
rrhythmic effects.